Cite
Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management
MLA
Kyriakie Sarafoglou, et al. “Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management.” The Journal of Clinical Endocrinology & Metabolism, Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........624e915aef6ff5c94bcd63ba67772bc4&authtype=sso&custid=ns315887.
APA
Kyriakie Sarafoglou, Deborah P Merke, Nicole Reisch, Hedi Claahsen-van der Grinten, Henrik Falhammar, & Richard J Auchus. (2023). Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management. The Journal of Clinical Endocrinology & Metabolism.
Chicago
Kyriakie Sarafoglou, Deborah P Merke, Nicole Reisch, Hedi Claahsen-van der Grinten, Henrik Falhammar, and Richard J Auchus. 2023. “Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management.” The Journal of Clinical Endocrinology & Metabolism, March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........624e915aef6ff5c94bcd63ba67772bc4&authtype=sso&custid=ns315887.